Institute of Behavioral Sciences, Semmelweis University, Budapest, Hungary.
Am J Kidney Dis. 2011 Sep;58(3):444-52. doi: 10.1053/j.ajkd.2011.03.028. Epub 2011 Jun 12.
Health-related quality of life (HRQoL) is an important outcome measure in patients with chronic kidney disease. It also has been shown repeatedly to predict mortality in various patient populations. In a prospective cohort study, we assessed the association between HRQoL and long-term clinical outcome in kidney transplant recipients.
Prospective prevalent cohort study.
SETTING & PARTICIPANTS: We collected sociodemographic parameters, medical and transplant history, and laboratory data at baseline from 879 prevalent kidney transplant recipients (mean age, 49 ± 13 [standard deviation] years; 58% men; and 17% with diabetes mellitus).
We assessed HRQoL using the KDQoL-SF (Kidney Disease Quality of Life Short Form) questionnaire and assessed depressive symptoms using the Center for Epidemiologic Studies-Depression Scale.
All-cause mortality and death-censored transplant loss or death with functioning transplant. Cox regression models and semiparametric competing-risks regression analyses were used to measure associations between HRQoL scores and outcomes.
Most examined HRQoL domains were associated with clinical outcome in unadjusted models. After adjusting for several important confounders, the 36-Item Short Form Health Survey (SF-36) Physical Composite Score and Physical Functioning and General Health Perception subscale scores remained independently associated with clinical outcomes. Every 10-point increase in SF-36 Physical Composite Score and Physical Functioning and General Health Perception scores was associated with 18% (HR, 0.82; 95% CI, 0.71-0.95), 11% (HR, 0.89; 95% CI, 0.84-0.94), and 7% lower risks of mortality (HR, 0.93; 95% CI, 0.88-1.00), respectively.
Single-center study.
We showed that the SF-36 Physical Composite Score and Physical Functioning and General Health Perception KDQoL-SF domain scores are associated independently with increased risk of mortality in kidney transplant patients. Regular assessment of HRQoL may be a useful tool to inform health care providers about the prognosis of kidney transplant recipients. Additional studies are needed to assess whether interventions aimed at improving HRQoL would improve clinical outcomes in this patient population.
健康相关生活质量(HRQoL)是慢性肾脏病患者的重要预后指标。它也已被多次证明可以预测各种患者群体的死亡率。在一项前瞻性队列研究中,我们评估了 HRQoL 与肾移植受者长期临床结局之间的关系。
前瞻性现患队列研究。
我们从 879 例现患肾移植受者(平均年龄 49 ± 13[标准差]岁;58%为男性;17%患有糖尿病)中收集人口统计学参数、医疗和移植史以及基线实验室数据。
我们使用 KDQoL-SF(肾脏病生活质量简表)问卷评估 HRQoL,并使用流行病学研究中心抑郁量表评估抑郁症状。
全因死亡率和死亡删失的移植失败或带功能移植的死亡。使用 Cox 回归模型和半参数竞争风险回归分析来测量 HRQoL 评分与结局之间的关联。
在未调整模型中,大多数检查的 HRQoL 领域与临床结局相关。在调整了几个重要的混杂因素后,36 项简明健康调查问卷(SF-36)生理综合评分以及生理功能和总体健康感知子量表评分仍与临床结局独立相关。SF-36 生理综合评分和生理功能和总体健康感知每增加 10 分,与死亡率降低 18%(HR,0.82;95%CI,0.71-0.95)、11%(HR,0.89;95%CI,0.84-0.94)和 7%(HR,0.93;95%CI,0.88-1.00)相关。
单中心研究。
我们表明,SF-36 生理综合评分和生理功能和总体健康感知 KDQoL-SF 域评分与肾移植患者的死亡率增加独立相关。定期评估 HRQoL 可能是向医疗保健提供者提供有关肾移植受者预后信息的有用工具。需要进一步的研究来评估旨在改善 HRQoL 的干预措施是否会改善该患者群体的临床结局。